COMMUNIQUÉS West-GlobeNewswire

Biotricity Announces the Addition of Artificial Intelligence to its Remote Patient Monitoring Platform

16/01/2018 - 14:00

REDWOOD CITY, Calif., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring [...]

RedHill Biopharma Announces Final Results from Phase II Study with BEKINDA® for IBS-D

16/01/2018 - 14:00

TEL-AVIV, Israel and RALEIGH, N.C., Jan. 16, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ: RDHL ) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]

Mitochondrial assay breakthrough announced by Biolog

16/01/2018 - 13:45

HAYWARD, Calif., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Biolog, Inc. announced today the launch of a new product line that enables a comprehensive scan of mitochondrial function. Better technology for measuring mitochondrial [...]

Transactions in relation to share buyback program

16/01/2018 - 13:39

Acting under its share buyback authorization, the GN Store Nord board of directors initiated a share buyback program on May 4, 2017 in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]

Innovation Pharmaceuticals Presents at 2018 Biotech Conference; Oral Mucositis Drug Candidate Garners Exceptional Interest After Successful Phase 2 Trial

16/01/2018 - 13:30

BEVERLY, Mass., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals, (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to inform shareholders of a productive appearance by [...]

AveXis Announces Proposed Public Offering of Common Stock

16/01/2018 - 13:25

CHICAGO, Jan. 16, 2018 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ: AVXS ) today announced that it intends to offer and sell, subject to market conditions, up to $400 million of shares of its common stock in an [...]

Saniona AB: Saniona initiates Phase I study with new Tesomet tablet

16/01/2018 - 13:20

PRESS RELEASE January 16, 2018 Saniona, a leading biotech company in the field of ion channels, today announced that it has dosed the first 10 participants in a Phase 1 pharmacokinetic study of Tesomet using the new [...]

AveXis Announces Expanded Clinical Development Program for AVXS-101 in Spinal Muscular Atrophy

16/01/2018 - 13:20

– Company to expand study of AVXS-101 into additional SMA populations including pre-symptomatic, older pediatric Type 2 and Type 3 SMA patients – – First patient dosed in Phase 1 trial of AVXS-101 in SMA Type 2 – [...]

FIT Biotech Oy: NOTICE CONVENING AN EXTRAORDINARY GENERAL MEETING OF FIT BIOTECH OY

16/01/2018 - 13:01

Company release January 16, 2018 at 2:00 PM EET NOTICE CONVENING AN EXTRAORDINARY GENERAL MEETING OF FIT BIOTECH OY The shareholders of FIT Biotech Oy are invited to an extraordinary general meeting, which is to be held [...]

Midatech and UCSF receive IND approval for DIPG treatment MTX110

16/01/2018 - 13:01

16 January 2018 Midatech Pharma PLC ("Midatech", "Company" or "Group") Midatech and UCSF receive IND approval for DIPG treatment MTX110 - First treatment in patients in US expected as scheduled in Q1 2018 Midatech [...]

Capricor Announces Licensing of Additional Patent Applications from Cedars-Sinai Medical Center for Cellular and Exosome-based Technologies

16/01/2018 - 13:00

LOS ANGELES, Jan. 16, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR ) announced today that it has added seven new patent applications to its existing Exclusive License Agreements with Cedars-Sinai Medical [...]

Leap Therapeutics Announces First Patient Dosed with TRX518 Combination Therapy in Advanced Solid Tumors Trial

16/01/2018 - 13:00

CAMBRIDGE, Mass., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (Nasdaq: LPTX ), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced that the first patient has been [...]

MPX Appoints New Chief Financial Officer

16/01/2018 - 13:00

TORONTO, Jan. 16, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (the “ Company ” or “ MPX ”) (CSE:MPX) (OTC:MPXEF) is pleased to announce the appointment of David McLaren as the Company’s new Chief Financial [...]

Cambrex & AstraZeneca Hold Ceremony to Mark Long-Term Supply Agreement at Karlskoga, Sweden Facility

16/01/2018 - 13:00

EAST RUTHERFORD, N.J., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM ), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today held an opening [...]

Anavex Life Sciences Reports Potential Normalization of Hypertension with ANAVEX®2-73 Published in The Journal of Clinical Hypertension

16/01/2018 - 13:00

NEW YORK, Jan. 16, 2018 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL ), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of [...]

Exergen Gears Up for Severe Cold and Flu Season

16/01/2018 - 13:00

WATERTOWN, Mass., Jan. 16, 2018 (GLOBE NEWSWIRE) -- As Australia’s flu season predicted earlier this year, North America is beginning to see the effects of a high intense flu season. The main flu strain for 2017-18 is [...]

Antares Pharma Provides XYOSTED™ Regulatory Update

16/01/2018 - 13:00

EWING, N.J., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS ) today announced that a Type A meeting has been scheduled with the U.S. Food and Drug Administration (FDA) on February 21, 2018 for [...]

Clean energy for Bio-on's new biopolymers "factory" thanks to a trigeneration plant built by Gruppo Hera

16/01/2018 - 08:01

Bologna, 16 January 2018 - Bio-on , the leader in eco-sustainable chemical technologies, and Gruppo Hera, one of Italy's main multi-utility providers, have reached an agreement for the supply of clean energy thanks to [...]

Une énergie propre pour la nouvelle « usine » de bio-polymères Bio-on, grâce à une installation tri-génératrice réalisée par Gruppo Hera

16/01/2018 - 08:01

Bologne, 16 janvier 2018 - Bio-on , société leader du secteur des technologies pour la chimie écologique, et Gruppo Hera , une des principales sociétés Multi-utility italiennes, ont conclu un accord de fourniture d'une [...]